| 11142521 |
Substituted anilines as CCR(4) antagonists |
Trevor T. Charvat, Junfa Fan, Christopher W. Lange, Yandong Li, Venkat Reddy Mali +4 more |
2021-10-12 |
| 11072597 |
Azolopyrimidine for the treatment of cancer-related disorders |
Joel Worley Beatty, Laurent P. Debien, Jenna Leigh Jeffrey, Debashis Mandal, Dillon Harding Miles +4 more |
2021-07-27 |
| 11058704 |
Inhibitors of adenosine 5′-nucleotidase |
Laurent P. Debien, Jaroslaw Kalisiak, Kenneth V. Lawson, Erick Allen Lindsey, Dillon Harding Miles +4 more |
2021-07-13 |
| 11045472 |
Quinazoline-pyridine derivatives for the treatment of cancer-related disorders |
Dillon Harding Miles, Jay P. Powers, Brandon Reid Rosen, Ehesan Ul Sharif, Rhiannon Thomas-Tran |
2021-06-29 |
| 11040960 |
Inhibitors of CXCR2 |
Xi Chen, Dean R. Dragoli, Junfa Fan, Jaroslaw Kalisiak, Viengkham Malathong +6 more |
2021-06-22 |
| 11001603 |
Modulators of 5′-nucleotidase, ecto and the use thereof |
Laurent P. Debien, Juan C. Jaen, Jaroslaw Kalisiak, Kenneth V. Lawson, Erick Allen Lindsey +5 more |
2021-05-11 |
| 10988464 |
Modulators of chemokine receptors |
Xi Chen, Dean R. Dragoli, Junfa Fan, Jaroslaw Kalisiak, Antoni Krasinski +7 more |
2021-04-27 |
| 10981944 |
Modulators of 5′-nucleotidase, ecto and the use thereof |
Laurent P. Debien, Juan C. Jaen, Jaroslaw Kalisiak, Kenneth V. Lawson, Erick Allen Lindsey +5 more |
2021-04-20 |